Key result
Clopidogrel plus aspirin versus aspirin alone for recurrent ischemic lesions after acute atherothrombotic stroke is discussed in this correspondence.
Key points are not available for this paper at this time.
Does not support changing post-stroke antiplatelet regimens; leaves open comparative efficacy for randomized trials.
To the Editor:
No takes yet. Share an insight, caveat, or question.
Moris et al. (2016) studied this question. Clopidogrel plus aspirin versus aspirin alone for recurrent ischemic lesions after acute atherothrombotic stroke is discussed in this correspondence.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: